SLBT — SL Science Holding Ltd
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 2070534 ·
Taiwan
Last close
$2.64
Market Cap
$1.48B
52W High
$14.50
52W Low
$2.54
ADV30
201,915
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 2,817,180 | 1,258,616 | 533,277 |
| Jun 2025 | — | — | — | — | 5,791,578 | 3,373,292 | 1,061,102 |
| Dec 2024 | — | — | — | — | 5,931,952 | 3,680,026 | 204,899 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-3,266,649
Inventory
$722,755
Receivables
$119,712
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,363,603
EBITDA
$-1,152,804
Free Cash Flow
$372,344
Enterprise Value
—
Total Cash
—
Total Debt
—
Shares Out
560,759,757
Trailing EPS
$-0.01
Book Value
—
ROE
-25.6%
ROA
-14.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,197,249 | -3,837,488 | -3,819,818 | 2,817,180 | 533,277 | — | -1,909,796 |
| Dec 2024 | 3,363,603 | -1,196,111 | -1,191,333 | 5,931,952 | 204,899 | — | 280,158 |
| Dec 2023 | 878,971 | 96,828 | 399,035 | 4,241,910 | 668,066 | — | -2,454,261 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | $1.49B | $26.92 | — |
| VIR | Vir Biotechnology, Inc. | $1.46B | $8.66 | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | $1.57B | $3.00 | — |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.40B | $16.52 | — |
| ALVO | Alvotech | $1.39B | $4.12 | — |
News headlines (Yahoo Finance, 1h cache)
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
2026-07-17 12:00 · Yahoo
Sector Update: Healthcare Stocks Decline Late Afternoon
2026-07-10 19:50 · Yahoo
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
2026-07-10 12:00 · Yahoo
Top Midday Decliners
2026-06-22 18:06 · Yahoo
SL Science Holding Limited Reports Full Year 2025 Financial Results
2026-06-18 21:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.